InvestSMART

ResMed Inc. (ASX: RMD) - Announcements

Current share price for RMD : $30.030 0.28 (0.92%)+

ASX company news and announcements for ResMed Inc. (RMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ResMed Inc. (RMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ResMed Inc. (RMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ResMed Inc. (RMD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$17,838 Half Year report and Form 10Q for December 31, 2010 4 Feb 2011 10:08AM $3.140 $30.030 risen by 856.37%
$17,838 Announces Management Changes 2 Feb 2011 8:27AM $3.070 $30.030 risen by 878.18%
$17,838 Financial results for the Quarter ended December 31, 2010 28 Jan 2011 9:16AM $3.190 $30.030 risen by 841.38%
$17,838 Financial results for the Quarter ended September 30, 2010 29 Oct 2010 9:32AM $3.410 $30.030 risen by 780.65%
$17,838 RESMED`S NEW CPAP DEVICE INCREASES PATIENT COMPLIANCE 17 Sep 2010 12:16PM $3.550 $30.030 risen by 745.92%
$17,838 Appendix 4E and Form 10-K 18 Aug 2010 9:42AM $3.600 $30.030 risen by 734.17%
$17,838 Financial results for 4th Qtr and Year ended 30 June 2010 6 Aug 2010 8:56AM $7.230 $30.030 risen by 315.35%
$17,838 Financial results for the Quarter ended March 31, 2010 30 Apr 2010 9:14AM $7.080 $30.030 risen by 324.15%
$17,838 Half Year Report 18 Feb 2010 3:18PM $6.420 $30.030 risen by 367.76%
$17,838 Form 10Q for Qtr ended December 31, 2009 8 Feb 2010 9:35AM $6.390 $30.030 risen by 369.95%
$17,838 Record Financial results - Qtr and Six months ended 31/12/09 5 Feb 2010 8:45AM $6.340 $30.030 risen by 373.66%
$17,838 Financial results for the Quarter ended September 30, 2009 6 Nov 2009 8:52AM $5.550 $30.030 risen by 441.08%
$17,838 Appendix 4E and Form 10K 24 Aug 2009 9:47AM $5.450 $30.030 risen by 451.01%
$17,838 Record Financial Results For The Qtr and Y/E June 30, 2009 7 Aug 2009 9:08AM $5.250 $30.030 risen by 472%
$17,838 Record results for the quarter ended March 31, 2009 8 May 2009 9:19AM $5.440 $30.030 risen by 452.02%
$17,838 Half Yearly Report and Accounts 9 Feb 2009 10:07AM $6.340 $30.030 risen by 373.66%
$17,838 Record Financial Results For The Qtr Ended Dec 31, 2008 6 Feb 2009 8:26AM $6.360 $30.030 risen by 372.17%
$17,838 Form 10-Q for the Quarter Ended Sep 30, 2008 7 Nov 2008 1:00PM $5.310 $30.030 risen by 465.54%
$17,838 Record Financial Results For The Qtr Ended Sep 30, 2008 7 Nov 2008 8:56AM $5.390 $30.030 risen by 457.14%
$17,838 HSBC Additional Credit Facility Agreement 7 Oct 2008 9:23AM $5.310 $30.030 risen by 465.54%
$17,838 Appendix 4E and Form 10-K 29 Aug 2008 9:44AM $5.560 $30.030 risen by 440.11%
$17,838 Record Financial Results For The Qtr and Year Ended 30/06/08 6 Aug 2008 9:12AM $5.070 $30.030 risen by 492.31%
$17,838 ResMed Statement Regarding Market Speculation 1 Jul 2008 1:37PM $3.920 $30.030 risen by 666.07%
$17,838 3Q FY 2008 Results For P/E March 31, 2008 2 May 2008 8:44AM $4.530 $30.030 risen by 562.91%
$17,838 Half Yearly Report and Accounts 11 Feb 2008 9:27AM $4.400 $30.030 risen by 582.50%

651 - 675 of 703 results

Page 27 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.